In addition, inhibiting IRE1α function by overexpressing a dominant negative IRE1α variant significantly increased overall host survival by decreasing tumor growth rate and angiogenesis in a model of glioma [55]. This evidence concerns the gene ERN1 and central nervous system cancer.